Delivery Order SPE2D018D0005-SPE2D324F290K

Award Date 9/30/24
Potential Completion Date 10/3/24
Potential Value $2.9K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Raritan, NJ 08869, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm fixed-price delivery order was awarded by the Defense Logistics Agency Troop Support Medical to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the provision of 150 milliliters of reagent anti-D bioclone. The contract has a potential value of $1,037.23 and a completion date of February 27, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that provides a range of diagnostic solutions, including analyzers, reagents, and...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract worth $1,037.23 to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, for the supply of 150 ml vials of Reagent Anti-D Bioclone. The contract has a completion date of February 21, 2024. Ortho-Clinical Diagnostics, Inc. is a self-certified HUBZone joint venture that has provided a range of diagnostic solutions, including COVID-19 tests and immunodiagnostic equipment,...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Ortho-Clinical Diagnostics Inc., a medical equipment manufacturing company, to provide 150ml of Reagent Anti-D Bioclone. The contract has a completion date of December 27, 2023 and a potential value of $5,186.15. Ortho-Clinical Diagnostics Inc. is a for-profit organization and self-certified HUBZone joint venture that manufactures a range of diagnostic solutions, including analyzers,...
The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, to provide 150 ml of REAGENT ANTI-D BIOCLONE. The contract has a completion date of January 25, 2024 and a potential value of $1,037.23. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that has previously provided medical equipment, reagents, and testing services to...
The Defense Logistics Agency Troop Support Medical awarded a $1,037.23 firm fixed price delivery order to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer, for the procurement of 150 ml monoclonal Anti-D reagent. This award is not associated with a set-aside program and has a completion date of March 6, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization that is self-certified as a HUBZone joint venture. They have provided a wide range of medical equipment,...
This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturer. The $1,037.23 firm fixed price delivery order is for the supply of 4566514555 REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The ultimate completion date for this contract is November 26, 2024. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and testing services to federal agencies...
This is a federal contract award to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer, by the Medical Supply Chain division of the Defense Department's Defense Health Agency. The $1,767.32 firm fixed-price delivery order is for the supply of 4,568,212,039 units of Anti-A,B Bioclone 15x10ml. The contract has a June 2, 2025 completion date and does not utilize a set-aside designation, indicating open competition. Ortho-Clinical Diagnostics, Inc. is a self-certified...
This is a firm fixed price delivery order contract awarded by the Medical Supply Chain division of the Defense Logistics Agency Troop Support to Ortho-Clinical Diagnostics, Inc., a for-profit medical equipment manufacturer. The $1,037.23 contract provides 150 milliliter bottles of Reagent Anti-D Bioclone, a critical diagnostic reagent. Ortho-Clinical Diagnostics has provided a range of medical equipment, reagents, and services to various federal healthcare agencies, including the Department of...
This federal contract award, with a ceiling value of $1,037.23, was issued by the Defense Health Agency to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company, for the provision of REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL. The contract is a delivery order with a firm fixed price pricing type and an ultimate completion date of November 25, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and self-certified HUBZone joint venture that has previously...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Ortho-Clinical Diagnostics, Inc., a medical equipment manufacturing company. The contract, valued at $1,037.23, is for the provision of REAGENT ANTI-D BIOCLONE 150ML MONOCLONAL, a medical supply item. The contract has a firm fixed price pricing type and a completion date of May 10, 2024. Ortho-Clinical Diagnostics, Inc. is a for-profit organization and a self-certified HUBZone joint venture manufacturer of...
  • SPE2D018D0005
    Indefinite Delivery Contract
  • SPE2D018D0005-SPE2D324F290K
    Delivery Order

This federal contract award to Ortho-Clinical Diagnostics, Inc., a self-certified HUBZone joint venture manufacturer, was issued by the Medical Supply Chain division of the Defense Logistics Agency. The $2,869.77 firm-fixed-price delivery order is for the supply of 150 ml bottles of Reagent Anti-D Bioclone, a critical medical reagent. The contract has an ultimate completion date of October 3, 2024. Ortho-Clinical Diagnostics has previously provided a range of medical equipment, reagents, and services to federal agencies such as the VA, DHA, and USDA. While no set-aside designation was applied to this award, the company has maintained several indefinite-delivery/indefinite-quantity contracts and blanket purchase agreements with these agencies to supply critical laboratory and blood bank products and services.

Generated 12/30/24, 1:30 PM